About this trial
In the event of suspected osteoarticular material infection (OAMI), broad-spectrum probabilistic antibiotic therapy is recommended immediately after revision surgery. There are no efficacy data to suggest that any particular to favour any particular molecule. However, the choice may depend on the impact on the microbiota and on Enterobacteriaceae colonization with multi-resistant Enterobacteriaceae. Our aim is to evaluate three different strategies efepime+daptomycin C+D, piperacillin-tazobactam+daptomycin (PT+D) and ceftobiprole (CFB).
Eligibility criteria
Qualifiers
Age ≥ 18 years
Indication for prosthetic revision (PTG, PUC, PTH or hip hemiarthroplasty, PTE) or internal osteosynthesis with suspicion of IOAM following the opinion of a Réunion de concertation Pluridisciplinaire (RCP) on complex osteoarticular infections
Normal CPK level according to laboratory standard
Social security affiliation
Disqualifiers
Antibiotic therapy in the 3 months prior to inclusion
Clinical or radiological signs making HAI highly probable: scar discharge and/or peri-scar cellulitis fistula or abscess, bacteremia
positive bacterial culture from joint puncture or biopsy prior to revision
Chronic inflammatory bowel disease.
Trial design
Treatments tested in this trial
- Stool sample 1
- Stool sample 2
- Stool sample 3